Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Evoke Pharma Inc | evok-ex311_9.htm |
| EX-31.2 - EX-31.2 - Evoke Pharma Inc | evok-ex312_8.htm |
| EX-32.2 - EX-32.2 - Evoke Pharma Inc | evok-ex322_7.htm |
| EX-32.1 - EX-32.1 - Evoke Pharma Inc | evok-ex321_10.htm |
| EX-10.18 - EX-10.18 - Evoke Pharma Inc | evok-ex1018_451.htm |
| 10-K - 10-K - Evoke Pharma Inc | evok-10k_20151231.htm |
| EX-10.20 - EX-10.20 - Evoke Pharma Inc | evok-ex1020_452.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in Registration Statements Form S-3 (No. 333-200176) and Form S-8 (No. 133-191518) of our report dated March 10, 2016, relating to the financial statements of Evoke Pharma, Inc. which appear in this Form 10-K. Our report contains an explanatory paragraph regarding the Company’s ability to continue as a going concern.
/s/ BDO USA, LLP
San Diego, California
March 10, 2016